Tofacitinib

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Therapies for Down Syndrome Regression Disorder

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome

Tofacitinib for Immune Skin Conditions in Down Syndrome